Quick Answer
BioNTech SE reported Total Assets of $21.99 billion for fiscal year 2025.
BioNTech SE — Key Financials by Year
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Total Assets | $21.99B -2.4% |
$22.53B -2.1% |
$23.01B -1.2% |
$23.28B +47.0% |
$15.83B +582.8% |
$2.32B +190.7% |
| R&D Expense | $2.10B -6.6% |
$2.25B +26.4% |
$1.78B +16.0% |
$1.54B +61.9% |
$949.20M +47.2% |
$645.00M +184.8% |
| Gross Profit | — | — | — | — | — | — |
- BioNTech SE reported Total Assets of $21.99 billion for fiscal year 2025.
- BioNTech SE showed a decrease of -2.4% in Total Assets compared to the prior fiscal year.
- BioNTech SE reported R&D Expense of $2.10 billion for fiscal year 2025.
- BioNTech SE showed a decrease of -6.6% in R&D Expense compared to the prior fiscal year.
- BioNTech SE reported Gross Profit of $91.23 million for fiscal year 2019.
- BioNTech SE showed a decrease of -19.9% in Gross Profit compared to the prior fiscal year.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: